Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10
OwnerMalaya Chatterjee, Kenneth A. Fooninventors
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of delaying development of HMFG-associated tumors using the anti-idiotype antibody 11D10, particularly in high-risk individuals having low tumor burden.
Claims24
A method of delaying development of a human milk fat globule (HMFG)-associated tumor in an individual having a low tumor burden of an HMFG-associated tumor, comprising administering to the individual an amount of anti-idiotype antibody 11D10 sufficient to delay development of said HMFG-associated tumor, wherein 11D10 is produced by a hybridoma cell line deposited at the American Type Culture Collection (ATCC) as Accession No. HB 12020, or progeny thereof, whereby development of said HMFG-associated tumor is delayed.
A method of treatment of a human milk fat globule (HMFG)-associated tumor in an individual with a low tumor burden of an HMFG-associated tumor, comprising administering to the individual an amount of anti-idiotype antibody 11D10 sufficient to treat said HMFG-associated tumor, wherein 11D10 is produced by a hybridoma cell line deposited at the American Type Culture Collection (ATCC) as Accession No. HB 12020, or progeny thereof, whereby said HMFG-associated tumor is treated.
Dependencies are inferred from the claim text.